- Home
- SOUN vs ARWR Comparison
SOUN vs ARWR Comparison
Compare SOUN & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOUN
- ARWR
- Stock Information
- Founded
- SOUN 2005
- ARWR 2003
- Country
- SOUN United States
- ARWR United States
- Employees
- SOUN N/A
- ARWR N/A
- Industry
- SOUN EDP Services
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- SOUN Technology
- ARWR Health Care
- Exchange
- SOUN Nasdaq
- ARWR Nasdaq
- Market Cap
- SOUN 5.2B
- ARWR 4.9B
- IPO Year
- SOUN N/A
- ARWR 1993
- Fundamental
- Price
- SOUN $20.86
- ARWR $35.96
- Analyst Decision
- SOUN Buy
- ARWR Strong Buy
- Analyst Count
- SOUN 7
- ARWR 8
- Target Price
- SOUN $14.50
- ARWR $47.75
- AVG Volume (30 Days)
- SOUN 70.7M
- ARWR 2.2M
- Earning Date
- SOUN 11-11-2025
- ARWR 11-25-2025
- Dividend Yield
- SOUN N/A
- ARWR N/A
- EPS Growth
- SOUN N/A
- ARWR N/A
- EPS
- SOUN N/A
- ARWR N/A
- Revenue
- SOUN $131,449,000.00
- ARWR $572,976,000.00
- Revenue This Year
- SOUN $100.21
- ARWR $21,421.26
- Revenue Next Year
- SOUN $29.10
- ARWR N/A
- P/E Ratio
- SOUN N/A
- ARWR N/A
- Revenue Growth
- SOUN 136.97
- ARWR 2816.20
- 52 Week Low
- SOUN $4.86
- ARWR $9.57
- 52 Week High
- SOUN $24.98
- ARWR $39.42
- Technical
- Relative Strength Index (RSI)
- SOUN 71.78
- ARWR 65.65
- Support Level
- SOUN $17.41
- ARWR $35.06
- Resistance Level
- SOUN $20.08
- ARWR $37.07
- Average True Range (ATR)
- SOUN 1.45
- ARWR 1.43
- MACD
- SOUN 0.19
- ARWR -0.26
- Stochastic Oscillator
- SOUN 89.25
- ARWR 56.83
About SOUN SoundHound AI Inc
SoundHound AI Inc is an innovator of conversational intelligence, offering an independent Voice AI platform that enables businesses across industries to deliver high-quality conversational experiences to customers. The company's voice AI delivers speed and accuracy in numerous languages to product creators and service providers across retail, financial services, healthcare, automotive, smart devices, and restaurants via groundbreaking AI-driven products like Smart Answering, Smart Ordering, Dynamic Drive-Thru, and Amelia AI Agents.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.